Advanced search×

In vivo Studies on Antidiabetic Plants Used in South African Herbal Medicine.

J Clin Biochem Nutr 47(2):98-106 (2010) PMID 20838564

Diabetes is one of the most common metabolic disorders worldwide. It is a major health problem with its frequency increasing every day in most countries. The disease is generally believed to be incurable; and the few orthodox drugs available to manage the disease are not readily affordable to the poor. Based on the historical success of natural products as antidiabetic agents and the ever increasing need for new antidiabetics, a number of South African medicinal plants have been evaluated for their antidiabetic properties. In this article, we review the major studies conducted based on ethnobotanical surveys carried out between 2005 and 2008 in South Africa on plants that are traditionally used for the treatment of diabetes. Overall, the results of the studies conducted confirmed the potential of South African medicinal plants in antidiabetic drug discovery and identified a number of promising taxa for further in vivo investigation as plant-based antidiabetic agents.

References 70 articles

DOI: 10.3164/jcbn.09-126R
Version: za2963e q8zae q8zb6 q8zc9 q8zde q8zeb q8zf2 q8zgb

Similar articles you may find interesting…

  1. A roadmap of cell-type specific gene expression during sequential stages of the arbuscular mycorrhiza symbiosis.

    BMC Genomics 14(1):306 (2013) PMID 23647797

    Our genome-wide analysis provides novel information on the cell-specific activity of AM-activated genes during both early and late stages of AM development, together revealing the road map of fine-tuned adjustments of transcript accumulation within root tissues during AM fungal colonization....
  2. Integrating HIV care into nurse-led primary health care services in South Africa: a synthesis of three linked qualitative studies.

    BMC Health Serv Res 13(1):171 (2013) PMID 23647922

    The integration of HIV care into primary care services is one of the strategies proposed to increase access to treatment for people living with HIV/AIDS in high HIV burden countries. However, how best to do this is poorly understood. This study documents different factors influencing models of integ...
  3. The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1...

    J Biol Chem (2013) PMID 23661707

    We find that the arrestin pathway-selective AT1 agonist, [Sar1,Ile4,Ile8]-AngII, but not the neutral AT1 antagonist, losartan, inhibits endogenous B2 receptor signaling. In a transfected HEK293 cell model that recapitulates this effect, we find that the actions of [Sar1,Ile4, Ile8]-AngII require the...